ZYUS Life Sciences Expands U.S. Patent Portfolio with Second Pain Management Patent

Issuance of U.S. patent supports ongoing clinical research in chronic and neuropathic pain SASKATOON, SK, May 5, 2026 /PRNewswire/ - ZYUS Life Sciences Corporation (the "Company") (TSXV: ZYUS), a clinical-stage life sciences company focused on the development and commercialization of...